Yongin, South Korea

Jin-Hyun Seong

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chong Kun Dang Pharmaceutical Corporation. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin-Hyun Seong. Retrieved from https://idiyas.com/inventor/jin-hyun-seong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jin-Hyun Seong in Erythropoietin Purification

Introduction: Jin-Hyun Seong is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of erythropoietin analogs. His innovative methods have the potential to enhance the efficiency and cost-effectiveness of biopharmaceutical production.

Latest Patents: Jin-Hyun Seong holds a patent titled "Methods for purifying erythropoietin analogs having lower isoelectric point." This invention relates to a method for purifying an erythropoietin analog with a low isoelectric point below 4. The process involves adding an N-linked sugar chain with high purity. The method allows for effective purification of the erythropoietin analog, which has more sialic acid residues, through three-step chromatographic processes. This innovation is notable for its ability to achieve purification in a shorter time and at a lower cost.

Career Highlights: Jin-Hyun Seong is currently associated with Chong Kun Dang Pharmaceutical Corporation, where he applies his expertise in biopharmaceuticals. His work focuses on improving the production processes of essential therapeutic proteins.

Collaborations: Jin-Hyun Seong collaborates with talented professionals in his field, including Cook-Hee Kim and Yeo-Wook Koh. Their combined efforts contribute to advancements in biopharmaceutical research and development.

Conclusion: Jin-Hyun Seong's innovative methods for purifying erythropoietin analogs represent a significant advancement in biopharmaceutical technology. His contributions are poised to impact the efficiency of drug production positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…